Obesity and female malignancies

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 29, Issue 4, 2015, Pages 528-540

  Benedetto, Chiara ^a   Salvagno, Francesca ^a   Canuto, Emilie Marion ^a   Gennarelli, Gianluca ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

breast cancer; cervical cancer; endometrial cancer; obesity; ovarian cancer; treatment

Indexed keywords

ADIPONECTIN; ANDROGEN; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; ESTROGEN; ESTROGEN RECEPTOR; ICOSANOID; INSULIN; INTERLEUKIN 6; LEPTIN; PROGESTERONE; PROGESTERONE RECEPTOR; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CHRONIC INFLAMMATION; CYTOREDUCTIVE SURGERY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HORMONAL THERAPY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; LAPAROSCOPY; LAPAROTOMY; LIFESTYLE MODIFICATION; LYMPH NODE DISSECTION; MINIMALLY INVASIVE SURGERY; OBESITY; OVARY CANCER; OVARY POLYCYSTIC DISEASE; OVERALL SURVIVAL; PATHOGENESIS; PEROPERATIVE COMPLICATION; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADICAL HYSTERECTOMY; ROBOT ASSISTED SURGERY; UTERINE CERVIX CANCER; WEIGHT REDUCTION; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; GENITAL NEOPLASMS, FEMALE; METABOLISM; NEOPLASM; OVARIAN NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; OBESITY; OVARIAN NEOPLASMS; RECEPTORS, ESTROGEN; UTERINE CERVICAL NEOPLASMS;

EID: 84929519125     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2015.01.003     Document Type: Article

References (97)

1. World Health Organization Obesity and overweight 2011 http://www.who.int/mediacentre/factsheets/fs311/en/index.html
2. American Cancer Society. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/.
3. K.Y. Wolin, K. Carson, and G.A. Colditz Obesity and cancer Oncologist 15 2010 556 565
4. S. Birks, A. Peeters, and K. Backholer A systematic review of the impact of weight loss on cancer incidence and mortality Obes Rev 13 2012 868 891
5. K.C. Hourdequin, W.L. Schpero, and D.R. McKenna Toxic effect of chemotherapy dosing using actual body weight in obese versus normal-weight patients: a systematic review and meta-analysis Ann Oncol 24 2013 2952 2962
6. K.A. Britton, J.M. Massaro, and J.M. Murabito Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality J Am Coll Cardiol 62 2013 921 925
7. N.A. Berger Obesity and cancer pathogenesis Ann N Y Acad Sci 1311 2014 57 76
8. World Health Organization. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx.
9. World Cancer Research Fund/American Institute for Cancer Research Food, nutrition, physical activity, and the prevention of breast Cancer 2010 http://www.dietandcancerreport.org/cancer-resource-center/downloads/Second-Expert-Report-full.pdf
10. K. Bhaskaran, I. Douglas, and H. Forbes Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults Lancet 384 2014 755 765
11. Z. Cheraghi, J. Poorolajal, and T. Hashem Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis PLoS One 7 2012 e51446
12. P.H. Lahmann, L. Lissner, and B. Gullberg A prospective study of adiposity and postmenopausal breast cancer risk: the Malmo Diet and Cancer Study Int J Cancer 103 2003 246 252
13. M.F. Munsell, B.L. Sprague, and D.A. Berry Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status Epidemiol Rev 36 2014 114 136
14. M. Wiseman The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective Proc Nutr Soc 67 2008 253 256
15. A. Amadou, P. Ferrari, and R. Muwonge Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis Obes Rev 14 2013 665 678
16. M.P. Cleary, and M.E. Grossmann Minireview: obesity and breast cancer: the estrogen connection Endocrinology 150 2009 2537 2542
17. M. Protani, M. Coory, and J.H. Martin Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis Breast Cancer Res Treat 123 2010 627 635
18. P.T. Bradshaw, J.G. Ibrahim, and J. Stevens Postdiagnosis change in bodyweight and survival after breast cancer diagnosis Epidemiology 23 2012 320 327
19. M. Ewertz, M.B. Jensen, and K.A. Gunnarsdottir Effect of obesity on prognosis after early-stage breast cancer J Clin Oncol 29 2011 25 31
20. R.E. Patterson, L.A. Cadmus, and J.A. Emond Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature Maturitas 66 2010 5 15
21. E.J. Crosbie, M. Zwahlen, and H.C. Kitchener Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis Cancer Epidemiol Biomarkers Prev 19 2010 3119 3130
22. Holman L, Lu K. The epidemiology of endometrial Cancer. In: Glob. libr. women's med., 10.3843/GLOWM.10236 I-D, editors. Glob libr women's med, (ISSN: 1756-2228); doi:103843/GLOWM102362012.
23. V.W. Setiawan, H.P. Yang, and M.C. Pike Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31 2013 2607 2618
24. J.A. Barry, M.M. Azizia, and P.J. Hardiman Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis Hum Reprod Update 20 2014 748 758
25. E.E. Calle, C. Rodriguez, and K. Walker-Thurmond Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 2003 1625 1638
26. H. Arem, and M.L. Irwin Obesity and endometrial cancer survival: a systematic review Int J Obes (Lond) 37 2013 634 639
27. C.C. Gunderson, J. Java, and K.N. Moore The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study Gynecol Oncol 133 2014 23 27
28. K. Basen-Engquist, C. Carmack, and J. Brown Response to an exercise intervention after endometrial cancer: differences between obese and non-obese survivors Gynecol Oncol 133 2014 48 55
29. A.N. Vargas Natural history of ovarian cancer Ecancermedicalscience 8 2014 465
30. A. du Bois, M. Quinn, and T. Thigpen 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) Ann Oncol 16 Suppl. 8 2005 viii7 viii12
31. C.M. Olsen, A.C. Green, and D.C. Whiteman Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis Eur J Cancer 43 2007 690 709
32. Collaborative Group on Epidemiological Studies of Ovarian Cancer Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies PLoS Med 9 2012 e1001200
33. C.M. Olsen, C.M. Nagle, and D.C. Whiteman Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium Endocr Relat Cancer 20 2013 251 262
34. M.M. Protani, C.M. Nagle, and P.M. Webb Obesity and ovarian cancer survival: a systematic review and meta-analysis Cancer Prev Res (Phila) 5 2012 901 910
35. H.S. Yang, C. Yoon, and S.K. Myung Effect of obesity on survival of women with epithelial ovarian cancer: a systematic review and meta-analysis of observational studies Int J Gynecol Cancer 21 2011 1525 1532
36. H.S. Bae, H.J. Kim, and J.H. Hong Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis J Ovarian Res 7 2014 41
37. P.J. Eifel, A. Jhingran, and D.C. Bodurka Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer J Clin Oncol 20 2002 3651 3657
38. C.C. Wee, E.P. McCarthy, and R.B. Davis Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med 132 2000 697 704
39. J.V. Lacey Jr., C.A. Swanson, and L.A. Brinton Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix Cancer 98 2003 814 821
40. S.S. Wang, M.E. Sherman, and A. Hildesheim Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000 Cancer 100 2004 1035 1044
41. M. Frumovitz, A. Jhingran, and P.T. Soliman Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer Obstet Gynecol 124 2014 1098 1104
42. L. Baglietto, D.R. English, and J.L. Hopper Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition Breast Cancer Res Treat 115 2009 171 179
43. S. Liedtke, M.E. Schmidt, and A. Vrieling Postmenopausal sex hormones in relation to body fat distribution Obesity (Silver Spring) 20 2012 1088 1095
44. J. Cuzick, I. Sestak, and M. Baum Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial Lancet Oncol 11 2010 1135 1141
45. S.E. Bulun, Z. Lin, and G. Imir Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment Pharmacol Rev 57 2005 359 383
46. K. Subbaramaiah, L.R. Howe, and P. Bhardwaj Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland Cancer Prev Res (Phila) 4 2011 329 346
47. X. Zhang, S.S. Tworoger, and A.H. Eliassen Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up Breast Cancer Res Treat 137 2013 883 892
48. S. Yang, K.W. Thiel, and K.K. Leslie Progesterone: the ultimate endometrial tumor suppressor Trends Endocrinol Metab 22 2011 145 152
49. M. Gottschau, S.K. Kjaer, and A. Jensen Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study Gynecol Oncol 136 2015 99 103
50. J. Ose, R.T. Fortner, and S. Rinaldi Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition Int J Cancer 136 2015 399 410
51. M.H. Faulds, and K. Dahlman-Wright Metabolic diseases and cancer risk Curr Opin Oncol 24 2012 58 61
52. C.J. Creighton, A. Casa, and Z. Lazard Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis J Clin Oncol 26 2008 4078 4085
53. S.J. Weroha, and P. Haluska IGF system in Cancer Endocrinol Metab Clin North Am 41 2012 335 350
54. M.J. Carlson, K.W. Thiel, and S. Yang Catch it before it kills: progesterone, obesity, and the prevention of endometrial cancer Discov Med 14 2012 215 222
55. Y.F. Huang, M.R. Shen, and K.F. Hsu Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer Br J Cancer 99 2008 1096 1102
56. W. Duan, X. Shen, and J. Lei Hyperglycemia, a neglected factor during cancer progression Biomed Res Int 2014 2014 461917
57. L. Gautron, and J.K. Elmquist Sixteen years and counting: an update on leptin in energy balance J Clin Invest 121 2011 2087 2093
58. A. Ray, K.J. Nkhata, and M.P. Cleary Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status Int J Oncol 30 2007 1499 1509
59. A. Lautenbach, A. Budde, and C.D. Wrann Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells Nutr Cancer 61 2009 484 491
60. V. Dubois, T. Jarde, and L. Delort Leptin induces a proliferative response in breast cancer cells but not in normal breast cells Nutr Cancer 66 2014 645 655
61. S. Uddin, R. Bu, and M. Ahmed Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer Mol Cancer 8 2009 74
62. C. Chen, Y.C. Chang, and M.S. Lan Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways Int J Oncol 42 2013 1113 1119
63. R.R. Gonzalez-Perez, Y. Xu, and S. Guo Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation Cell Signal 22 2010 1350 1362
64. D. Macis, A. Guerrieri-Gonzaga, and S. Gandini Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis Int J Epidemiol 43 2014 1226 1236
65. W. Gu, C. Chen, and K.N. Zhao Obesity-associated endometrial and cervical cancers Front Biosci (Elite Ed 5 2013 109 118
66. M.E. Grossmann, A. Ray, and S. Dogan Balance of adiponectin and leptin modulates breast cancer cell growth Cell Res 18 2008 1154 1156
67. C.M. Friedenreich, H.K. Neilson, and C.G. Woolcott Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women Endocr Relat Cancer 18 2011 357 369
68. M. Ono Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy Cancer Sci 99 2008 1501 1506
69. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
70. C.A. Gilbert, and J.M. Slingerland Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression Annu Rev Med 64 2013 45 57
71. P.G. Morris, C.A. Hudis, and D. Giri Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer Cancer Prev Res (Phila) 4 2011 1021 1029
72. L.W. Bowers, A.J. Brenner, and S.D. Hursting Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production Breast Cancer Res Treat 2014
73. R.E. Harris, B.C. Casto, and Z.M. Harris Cyclooxygenase-2 and the inflammogenesis of breast cancer World J Clin Oncol 10 2014 677 692
74. L.W. Bowers, I.X. Maximo, and A.J. Brenner NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions Cancer Res 74 2014 4446 4457
75. S.C. Modesitt, C. Tian, and R. Kryscio Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study Gynecol Oncol 105 2007 59 65
76. G. Au-Yeung, P.M. Webb, and A. DeFazio Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS) Gynecol Oncol 133 2014 16 22
77. J.J. Griggs, P.B. Mangu, and H. Anderson Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline J Clin Oncol 30 2012 1553 1561
78. S.J. Ioannides, P.L. Barlow, and J.M. Elwood Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review Breast Cancer Res Treat 147 2014 237 248
79. E.J. Folkerd, J.M. Dixon, and L. Renshaw Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer J Clin Oncol 30 2012 2977 2980
80. I. Sestak, W. Distler, and J.F. Forbes Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial J Clin Oncol 28 2010 3411 3415
81. M. Bodmer, C. Meier, and S. Krahenbuhl Long-term metformin use is associated with decreased risk of breast cancer Diabetes Care 33 2010 1304 1308
82. R. Shao, X. Li, and Y. Feng Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma J Exp Clin Cancer Res 33 2014 41
83. M.N. Shafiee, G. Khan, and R. Ariffin Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help? Gynecol Oncol 132 2014 248 253
84. E.M. Ko, P. Walter, and A. Jackson Metformin is associated with improved survival in endometrial cancer Gynecol Oncol 132 2014 438 442
85. E.J. Gallagher, and D. LeRoith Diabetes, cancer, and metformin: connections of metabolism and cell proliferation Ann N Y Acad Sci 1243 2011 54 68
86. K.N. Slaughter, T. Thai, and S. Penaroza Measurements of adiposity as clinical biomarkers for first-line bevacizumab-based chemotherapy in epithelial ovarian cancer Gynecol Oncol 133 2014 11 15
87. L.L. Lin, L. Hertan, and R. Rengan Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance Int J Radiat Oncol Biol Phys 83 2012 670 675
88. K. Galaal, A. Bryant, and A.D. Fisher Laparoscopy versus laparotomy for the management of early stage endometrial cancer Cochrane Database Syst Rev 9 2012 CD006655
89. I.E. Martinek, K. Haldar, and R. Tozzi Laparoscopic surgery for gynaecological cancers in obese women Maturitas 65 2010 320 324
90. H. Mahdi, A.M. Jernigan, and Q. Aljebori The impact of obesity on the 30-day morbidity and mortality after surgery for endometrial cancer J Minim Invasive Gynecol 22 2015 94 102
91. A. du Bois, A. Reuss, and E. Pujade-Lauraine Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) Cancer 115 2009 1234 1244
92. F.J. Backes, C.I. Nagel, and E. Bussewitz The impact of body weight on ovarian cancer outcomes Int J Gynecol Cancer 21 2011 1601 1605
93. A. Kumar, J.N. Bakkum-Gamez, and A.L. Weaver Impact of obesity on surgical and oncologic outcomes in ovarian cancer Gynecol Oncol 135 2014 19 24
94. C. Fotopoulou, R. Richter, and E.I. Braicu Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking Ann Surg Oncol 18 2011 2629 2637
95. M. Frumovitz, C.C. Sun, and A. Jhingran Radical hysterectomy in obese and morbidly obese women with cervical cancer Obstet Gynecol 112 2008 899 905
96. M.C. Salman, A. Usubutun, and T. Ozlu Obesity does not affect the number of retrieved lymph nodes and the rate of intraoperative complications in gynecologic cancers J Gynecol Oncol 21 2010 24 28
97. A.K. Sinno, and A.N. Fader Robotic-assisted surgery in gynecologic oncology Fertil Steril 102 2014 922 932